Provided by Tiger Fintech (Singapore) Pte. Ltd.

Unity Biotechnology

0.9770
-0.0067-0.68%
Post-market: 1.020.0430+4.40%18:26 EDT
Volume:88.15K
Turnover:88.95K
Market Cap:16.82M
PE:-0.60
High:1.04
Open:1.00
Low:0.9760
Close:0.9837
Loading ...

UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema

GlobeNewswire
·
24 Mar

UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025

GlobeNewswire
·
24 Mar

BRIEF-UNITY Biotechnology appoints Yehia Hashad to its board

Reuters
·
10 Mar

Unity Biotechnology Is Maintained at Buy by Chardan Capital

Dow Jones
·
10 Mar

UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.d., to the Board of Directors

THOMSON REUTERS
·
10 Mar

Press Release: UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors

Dow Jones
·
10 Mar

Unity Biotechnology Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Mar

Unity Biotechnology Reports 2024 Financial Results and Updates

TIPRANKS
·
09 Mar

Unity Biotechnology reports Q4 EPS (50c) vs. (28c) last year

TIPRANKS
·
08 Mar

Unity Biotechnology Q4 2024 GAAP EPS $(0.50) Misses $(0.39) Estimate

Benzinga
·
08 Mar

BRIEF-Unity Biotechnology Q4 Operating Income USD -9.991 Million

Reuters
·
08 Mar

UNITY Biotechnology Q4 Operating Expenses USD 9.991 Million

THOMSON REUTERS
·
08 Mar

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

GlobeNewswire
·
08 Mar

BRIEF-Unity Biotechnology Appoints Federico Grossi As Chief Medical Officer

Reuters
·
06 Jan

UNITY Biotechnology Announces Appointment of Federico Grossi, M.d., Ph.d., as Chief Medical Officer

THOMSON REUTERS
·
06 Jan

Press Release: UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer

Dow Jones
·
06 Jan

We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate

Simply Wall St.
·
05 Jan

Unity Biotech Faces Regulatory Risks: Potential Legal and Financial Consequences Loom

TIPRANKS
·
06 Nov 2024

Unity Biotechnology Focuses on Promising DME Treatment

TIPRANKS
·
05 Nov 2024

Unity Biotechnology Q3 2024 GAAP EPS $(0.38) Beats $(0.40) Estimate

Benzinga
·
05 Nov 2024